GTC Biotherapeutics (fka GTCB)

[DewDiligence]

FTC Requests More Information on Talecris Acquisition

[I see no reason why this deal won’t eventually go through, although some small divestment might be needed to satisfy the regulators.]

http://www.reuters.com/article/marketsNews/idINSYU00527720081012

›Sun Oct 12, 2008 6:44pm EDT

MELBOURNE, Oct 13 (Reuters) - Australia's CSL Ltd (CSL.AX), the world's top plasma products group, said on Monday the U.S. Federal Trade Commission had asked it for more information on its proposed $3.1 billion takeover of smaller U.S. rival Talecris Biotherapeutics.

The request is a normal part of the anti-trust review process, it said.

"CSL and Talecris are co-operating with the FTC to respond to the request and obtain the necessary regulatory approvals to secure timely closure of the acquisition," the company said.‹